Clinical Trials Directory

Trials / Completed

CompletedNCT06351579

Data Collection Post Radical Prostatectomy

A Look at Outcomes After Post Radical Prostatectomy

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Levee Medical, Inc. · Industry
Sex
Male
Age
45 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The study is designed to collect information on patients undergoing radical prostatectomy (RP), with a primary focus on the occurrence, duration, and severity of post-prostatectomy incontinence. Data will be collected at multiple time points, allowing for a dynamic understanding of urinary incontinence patterns at post RP.

Detailed description

Urinary incontinence (UI) is predominantly iatrogenic following radical prostatectomy (RP). Surgical removal of the prostate leads to a shortened urethra, widened bladder neck, and diminished urethral support. This results in increased demand on the urinary sphincter to maintain urinary continence. Most men will experience acute urinary incontinence following RP. Continence progressively improves over time; however, it is estimated that between 5-15% of men will experience chronic urinary incontinence. Current treatments for post-prostatectomy urinary incontinence include conservative therapies such as pelvic floor muscle training and surgical treatments. The sponsor is conducting a feasibility study (ARID) using a medical device to improve / reduce UI rate at post-RP. This study (ALTO) is designed as a control cohort to collect information on patients undergoing radical prostatectomy (RP) without using the device. This ALTO study is to systematically collect detailed information on patients undergoing radical prostatectomy, with a primary focus on the occurrence, duration, and severity of post-prostatectomy incontinence. Data will be collected at multiple time points, allowing for a dynamic understanding of urinary incontinence patterns at post RP.

Conditions

Interventions

TypeNameDescription
OTHERControlThis is an observational (registry) study for data collection only. No device or intervention will be used in this study.

Timeline

Start date
2023-03-30
Primary completion
2025-07-30
Completion
2025-07-30
First posted
2024-04-08
Last updated
2025-09-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06351579. Inclusion in this directory is not an endorsement.